Bone and Joint Health Ingredient Market Research Report—Global Forecast till 2028

Bone And Joint Health Ingredient Market Global Research Report by Type [Calcium, Collagen, Glucosamine, Chondroitin, Magnesium, and Vitamins], Application (Nutraceuticals & dietary supplements, Food and Beverages, and Pharmaceuticals), and Region (North America, Europe, Asia-Pacific, and Rest of the World) —Forecast till 2028

ID: MRFR/F-B & N/3258-CR | September 2022 | Region: Global | 90 Pages         

Bone Joint Health Ingredients Market Speak to Analyst Request a Free Sample

Bone and Joint Health ingredients Market

Bone and joint health ingredients market is projected to of USD 28,481.78 million by 2028 at CAGR of 7.69%.

Segmentation
By Ingredient Type Calcium Collagen Glucosamine Chondroitin Magnesium Vitamins
By Application Food & Beverages Pharmaceuticals Nutraceuticals & Dietary Supplements
By Region North America Europe Asia-Pacific the Rest of the World
Key Players
Companies Profiled   Synutra Inc.    Royal DSM NV    Archer Daniels Midland Company    BASF SE    DuPont De Nemours Inc.    Waitaki Bio    Rousselot    Glanbia PLC    Koninklijke DSM NV    Holista Colltech Limited    Bioiberica SA    Bergstorm Nutrition Inc    Cargill Incorporated    Holista Colltech Limited    ESM Technologies LLC.
Drivers
Market Driving Forces   Increasing adoption of bone and joint health ingredients    Growing demand for bone and joint health ingredients in functional food & beverages and dietary supplements
Request a Free Sample

Bone and Joint Health Ingredient Market Overview


global bone and joint health ingredient market share is projected to register a CAGR of 7.69% and reach a value of USD 28,481.78 million by 2028. The growth of the global bone and joint health ingredient market is attributed to the rising prevalence of bone and joint disorder and growing demand for bone and joint health ingredients among elderly population in functional food & beverages and dietary supplements. However, increasing awareness regarding side effects of bone and joint health ingredient products may hamper the market growth. Furthermore, the emerging markets of bone and joint health ingredient pose as viable opportunities for market expansion in the future.


COVID-19 Impact Analysis


The rising prevalence of COVID-19 is projected to influence market growth over the forecast period. The COVID-19 crisis has a direct and huge impact on the healthcare sector. During the initial stage of the coronavirus outbreak, most pharmaceutical and nutraceutical companies experienced a slight loss in the first few quarters, owing to the sudden impact on the supply chain and restrictions implemented on manufacturing and supply operations. However, COVID-19 has led to an increased demand for nutraceuticals, including bone & joint health ingredients. Several key players have witnessed positive growth in sales due to the growth in demand.


Market Dynamics


The global bone and joint health ingredient market has witnessed a significant growth rate over the last few years and is projected to register a 7.69% CAGR during the forecast period The growing demand for bone and joint health ingredients in functional food & beverages and dietary supplements, rising demand for bone and joint health ingredients in the elderly population, and increasing prevalence of orthopedic diseases are expected to propel the market growth. However, factors such as side effects associated with the bone and joint ingredients and stringent government regulations are expected to hamper the growth of the market. Nevertheless, untapped markets in developing economies, growth strategies by key players, and the influence of social media and innovative marketing strategies are projected to provide lucrative growth opportunities for the market in the near future.


Drivers:

  • Rising prevalence of Orthopedic Diseases


The prevalence of orthopedic diseases such as osteoporosis, osteoarthritis, and obesity has increased the number of surgical procedures, which has resulted in the high demand for bone and joint health ingredients. As per the Centers for Disease Control and Prevention (CDC), osteoarthritis affects over 32.5 million US adults. Moreover, according to the Arthritis Society, in Canada, about 20% of the population aged above 15 has arthritis. According to WHO, osteoarthritis is estimated to affect above 40 million people across Europe. Thus, the increasing prevalence of orthopedic diseases worldwide is expected to propel the growth of the bone and joint health ingredient market. In addition, the recommended daily intake of calcium is 1,000 mg per day for most adults, though women over 50 and everyone over 70 should get 1,200 mg per day. Several reports have found that Asian populations are evidently under calcium deficiency. The low calcium intake is responsible for increased bone resorption and low bone mineral density. Evidently, in China, osteoporosis affects almost 70 million people over the age of 50 and causes some 687,000 hip fractures each year. Moreover, in India, approximately 180 million of the population have arthritis. Thus, the rising prevalence of orthopedic diseases drives the growth of the market.


Restraint:

  • Side Effects associated with the bone and joint ingredients


The use of dietary supplements is increasing among consumers. The products are widely available in various shapes and flavors, providing the needed nutrients to the body. However, certain side effects are associated with the overconsumption of dietary supplements, which restrict the market's growth. For instance, calcium supplements may cause bloating, gas, and constipation. Overconsumption of calcium supplements increases the risk for the development of kidney stones. Hypercalcemia is a condition in which the calcium level in the blood is above normal. Likewise, collagen supplements can cause digestive side effects, such as feelings of fullness and heartburn. Similarly, the overconsumption of vitamins and minerals also has toxic effects on the body.


Opportunities:

  • Untapped markets in Developing Economies


The demand for bone and joint health ingredients is high in the developed countries of North America and Europe. However, the products have only recently gained acceptance in developing nations such as China, India, and Brazil. The increasing incidence rate of malnutrition and various nutrient deficiencies have focused on the recommended daily allowance (RDA) of nutrient vitamins and minerals. Several reports have found that Asian populations are evidently under calcium deficiency. According to a research article published in Osteoporos Sarcopenia, in 2020, the mean calcium intakes in Japan and Korea were approximately 500 mg/day or less. This low calcium intake is responsible for increased bone resorption and low bone mineral density. Moreover, the increasing health consciousness in these countries has also led to a rise in the consumption of bone and joint health ingredients. Thus, manufacturers of bone and joint health ingredients are shifting focus to product launches that cater to the populations in untapped markets. For instance, in March 2020, BASF launched state-of-the-art sports nutrition such as Active Mobi-lite ingredient in China. This ingredient aids in maintaining bone density and supports joint health for adults and seniors. Additionally, the growth of the organized retail sector in countries such as India and China offer lucrative opportunities to players in the global bone and joint health ingredient market.


Segment Overview


By Type


Based on type, the global bone and joint health ingredient market has been segmented into Calcium, collagen, glucosamine, chondroitin, magnesium, and vitamins. The Vitamin segment accounted for the largest market share of USD 8,254.34 Million in 2020 whereas Collagen segment is projected to record the highest CAGR of 10.62% during the forecast period.


By Application


Based on Application, the global bone and joint health ingredient market has been segmented into Nutraceuticals & dietary supplements, Food and Beverages, and Pharmaceuticals. The Nutraceuticals & dietary supplements segment accounted for a larger market share of 65.55% in 2020 and it is expected to record the highest CAGR of 8.60% during the forecast period.


Global Bone and joint health ingredient Market Share, by Region, 2020 (%)Bone and joint health ingredient Market Share, by Region, 2020 (%)Sources: MRFR Analysis


Regional Analysis


By region, the global Bone and joint health ingredient market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. Asia-Pacific accounted for the largest market share of 32.60% in 2020 and it exhibit the highest CAGR of 8.20% during the review period. Europe was the second-largest market in 2020 and is projected to exhibit a CAGR of 7.07% during the review period. The market in North America is expected to register a CAGR of 7.87% during the forecast period.


Asia-Pacific


Asia-Pacific accounted for the largest market share of 32.60% of the global bone and joint health ingredient market in 2020 and is projected to expand at an 8.20% highest CAGR during the forecast period. Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2021 to 2028; this is due to the high incidence of arthritis and osteoporosis, improving healthcare, increasing per capita disposable income, and increasing bone and joint health awareness. A large number of adults residing in the region are expected to suffer from various orthopedic disorders. The recommended daily calcium intake is 1,000 mg per day for most adults, though women over 50 and everyone over 70 should get 1,200 mg per day. Several reports have found that Asian populations are evidently under calcium deficiency. According to a research article published in Osteoporos Sarcopenia, in 2020, the mean calcium intakes in Japan and Korea were approximately 500 mg/day or less. This low calcium intake is responsible for increased bone resorption and low bone mineral density.


Europe


Europe accounted for the second-largest market share of 28.80% of the Bone and joint health ingredient market in 2020. The regional market is expected to register a CAGR of 7.07% during the forecast period. Europe is anticipated to witness significant growth over the forecast period due to a higher number of patients suffering from bone and joint-related disorders, the availability of products in the region, and the growing geriatric population. According to WHO, osteoarthritis is estimated to affect above 40 million people across Europe. Moreover, according to Organisation for Economic Co-operation and Development (OECD), in 2020, Switzerland, Finland, Luxembourg, Germany, Austria, and Belgium were among the countries with the highest number of hip and knee replacements in the region. The number of hip and knee replacement procedures has increased rapidly in most OECD countries. Between 2010 and 2020, hip replacement rates increased by 30% and knee replacement rates by 40%.   


Competitive Landscape


The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have a global reach and diverse product portfolios. Companies such as DSM (Netherlands), BASF SE (Germany), Archer-Daniels-Midland Company (ADM) (US), Glanbia PLC (Ireland), and Lonza Group (Switzerland) dominate the global market due to brand reputation, product differentiation, financial stability, and diversified regional presence.


Prominent players in the global Bone and joint health ingredient market include DSM (Netherlands), BASF SE (Germany), Archer-Daniels-Midland Company (ADM) (US), Glanbia PLC (Ireland), Lonza Group (Switzerland), Stratum Nutrition (US), PharmaZen Limited (New Zealand), Darling Ingredients (US), Holista Colltech (Australia), Bioiberica S.A.U. (Spain).


Scope of the Report


Global Bone and joint health ingredient Market, by Type



  • Calcium

  • Collagen

  • Glucosamine

  • Chondroitin

  • Magnesium

  • Vitamins


Global Bone and joint health ingredient Market, by Application



  • Nutraceuticals & dietary supplements

  • Food and Beverages

  • Pharmaceuticals


Global Bone and joint health ingredient Market, by Region




  • North America

    • US

    • Canada

    • Mexico




  • Europe

    • UK

    • Germany

    • France

    • Spain

    • Italy

    • Russia

    • Rest of Europe




  • Asia-Pacific

    • China

    • India

    • Japan

    • Australia & New Zealand

    • Rest of Asia-Pacific




  • Rest of the World

    • South America

    • Middle East

    • Africa




Intended Audience



  • Pharmaceutical

  • Personal Care

  • Retailers, Wholesalers, and Distributors

  • Governments, Associations, and Industrial Bodies

  • Hospitals



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 28,481.78 million
  CAGR   7.69%
  Base Year   2020
  Forecast Period   2021-2028
  Historical Data   2019
  Forecast Units   Value (USD million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   by Type, Application, and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   DSM (Netherlands), BASF SE (Germany), Archer-Daniels-Midland Company (ADM) (US), Glanbia PLC (Ireland), Lonza Group (Switzerland), Stratum Nutrition (US), PharmaZen Limited (New Zealand), Darling Ingredients (US), Holista Colltech (Australia), Bioiberica S.A.U. (Spain).
  Key Market Opportunities    increasing incidence rate of malnutrition
  Key Market Drivers   Rising prevalence of Orthopedic Diseases


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Bone and joint health ingredients market is projected to grow at a 7.69% CAGR between 2021-2028.

North America is expected to dominate the bone and joint health ingredients market.

Bone and joint health ingredients market is predicted to touch USD 28,481.78 million by 2028.

Nutraceuticals and dietary supplements will lead the bone and joint health ingredients market.

High cost may limit the bone and joint health ingredients market.